Loss of p16 and p27 is associated with progression of human gastric cancer

Cancer Letters

Volumn 153, Issue 1-2, 2000, Pages 129-136

  Myung, Nahye ^a   Kim, Mi Ran ^b   Chung, In Pyung ^b   Kim, Hanseong ^b   Jang, Ja June ^b  

^a Dankook University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

G1 check point cell cycle proteins; Immunohistochemical expression; Progression of gastric tumors

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROTEIN P16; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR GROWTH;

CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DISEASE PROGRESSION; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0034729281     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00359-1     Document Type: Article

References (22)

1. KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis. 18:1997;1139-1148.
2. Clurman B.E., Roberts J.M. Cell cycle and cancer (Editorials). J. Nat. Cancer Inst. (87):1995;499-501.
3. Dutta A., Chandra R., Letter L.M., Lester S. Cyclins as markers of tumor proliferations: Immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5386-5390.
4. Zhang S.Y., Caamano J., Cooper F. Guo. A. Klein-Szanto, Immunohistochemistry of cyclin D1 in human breast cancer, Am. J. Clin. Pathol. 102:1994;695-698.
5. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
6. Akama Y., Yasui W., Yokozaki H., Kuniyasu H., Kitahara K., Ishikawa T., Tahara E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Rapid communication. Jpn. J. Cancer Res. 86:1995;617-621.
7. Yasui W., Kudo Y., Semba S., Yokozaki H., Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Rapid communication. Jpn. J. Cancer Res. 88:1997;6250-6259.
8. Cohen J.A., Geradts J. Loss of RB and MTS/CDKN2 (p16) expression in human sarcomas. Hum. Pathol. 28:1997;893-898.
9. Cordon-Cardo C. Review. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 147:1995;545-560.
10. Devita V.T. Jr., Hellman S., Rosenberg S.A. Principles & Practice of Oncology, 5th Edition. 1977;121-129 Lippincott-Raven, Philadelphia PA
11. INK4 expression in human breast cancer, Am. J. Pathol. 149:1996;15-20.
12. Geradts J., Kratzke R.A., Crush-Stanton S., Wen S.F., Lincoln C.E. Wild-type and mutant retinoblastoma protein in paraffin sections. Mod. Pathol. 9:1996;339-347.
13. 1a,b) invasive breast carcinomas, Cancer Res. 57:1997;1259-1263.
14. KIP1 protein; Prognosis implications in primary breast cancer. Nat. Med. 3:1997;227-230.
15. Loda M., Cukor B., Tam S.W., Lavin P., Fiorentino M., Draetta G.F., Jessup M., Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:1997;231-234.
16. INK4 expression in primary lung cancers and cell lines. Cancer Res. 55:1995;505-509.
17. Cote R.J., Dunn M.D., Chatterjee S.J., Stein J.P., Shi S.R., Tran Q.C., Hu S.X., Xu H.J., Groshen S., Taylor C.R., Skinner D.G., Benedict W.F. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res. 58:1998;1090-1094.
18. Geradts J., Hu S.X., Lincoln C.E., Benedict W.F., Xu H.J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer. 58:1994;161-167.
19. Sakaguchi M., Fujii Y., Hirabayashi H., Yoon H.E., Komoto Y., Oue T., Kusafuka T., Okada A., Matsuda H. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study. Int. J. Cancer. 65:1996;442-445.
20. KIP1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients, Nat. Med. 3:1997;222-225.
21. Lee C.C.R., Yamamoto S., Wanibuchi H., Wada S., Sugimura K., Kishimoto T., Fukushima S. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation, Cancer Res. 57:1997;4765-4776.
22. Sasano H., Frost A.R., Saitoh R., Taniyama Y., Nagura H., Matsunaga G., Takehana K., Kimura M., Silverberg S.G. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Anticancer Res. 17:1997;3685-3690.